Literature DB >> 6440907

Evaluation of a C-reactive protein latex agglutination detection test with sera from patients with sexually transmitted diseases.

W O Schalla, R J Arko, S E Thompson.   

Abstract

A total of 149 sera, including 79 pre- and posttreatment sera from 33 patients with disseminated gonococcal infections, 18 from patients with uncomplicated gonococcal infections, 6 from patients with pelvic inflammatory disease, 4 from patients with genital Chlamydia trachomatis infections, and 42 from normal volunteers, were examined for C-reactive protein with a latex agglutination C-reactive protein detection kit (Difco Laboratories, Detroit, Mich.). Results were quantitated with LC-Partigen C-reactive protein radial immuno-diffusion plates (Calbiochem-Behring, La Jolla, Calif.). Positive latex agglutination results were observed in all of the pretreatment sera and some of the posttreatment sera of patients with disseminated gonococcal infections and in two sera from patients with pelvic inflammatory disease, which corresponded to quantitative C-reactive protein levels in the radial immunodiffusion plates. C-reactive protein levels were not detectable in the serum samples from normal volunteers or patients with uncomplicated gonococcal infections or genital chlamydial infections. Positive latex agglutination occurred as early as 20 s in sera with high C-reactive protein levels, and all positive results were observed within 90 s of the 3-min test limit. Positive latex test results were obtained with C-reactive protein levels as low as 1 mg/dl (10 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440907      PMCID: PMC271539          DOI: 10.1128/jcm.20.6.1171-1173.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy.

Authors:  L Jacobson; L Weström
Journal:  Am J Obstet Gynecol       Date:  1969-12-01       Impact factor: 8.661

2.  Comparative studies on the binding properties of human and rabbit C-reactive proteins.

Authors:  E B Oliveira; E C Gotschlich; T Y Liu
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

Review 3.  Complement activation by C-reactive protein complexes.

Authors:  J E Volanakis
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

Review 5.  Binding of C-reactive protein to C-carbohydrate and PC-substituted protein.

Authors:  E C Gotschlich; T Y Liu; E Oliveira
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

7.  Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms.

Authors:  J P O'Brien; D L Goldenberg; P A Rice
Journal:  Medicine (Baltimore)       Date:  1983-11       Impact factor: 1.889

8.  The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients.

Authors:  S E Thompson; W D Hager; K H Wong; B Lopez; C Ramsey; S D Allen; M D Stargel; C Thornsberry; B B Benigno; J D Thompson; J A Shulman
Journal:  Am J Obstet Gynecol       Date:  1980-01-15       Impact factor: 8.661

9.  Opsonic properties of C-reactive protein in vivo.

Authors:  S Nakayama; C Mold; H Gewurz; T W du Clos
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

10.  C-reactive protein is protective against Streptococcus pneumoniae infection in mice.

Authors:  C Mold; S Nakayama; T J Holzer; H Gewurz; T W Du Clos
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  1 in total

1.  Serum CRP in the diagnosis and treatment of pelvic inflammatory disease.

Authors:  M Hemilä; L Henriksson; O Ylikorkala
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.